Statins in Reducing Events in the Elderly (STAREE) Heart Sub-study
NCT ID: NCT04536870
Last Updated: 2025-04-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
369 participants
INTERVENTIONAL
2019-12-12
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Statins in Reducing Events in the Elderly Mind (STAREE-Mind) Imaging Substudy
NCT05586750
Prior Statin Use and Risk of CHF, ALO and Malignant Arrhythmia in Indonesian Post-Acute Coronary Syndrome Patients
NCT03596931
Atorvastatin Pre-Treatment Study In Asian Patients With Acute Coronary Syndrome
NCT00728988
Effect of Upstream Treatment With High Intensity Statin on the Outcomes of STMI Patients Treated With PPCI
NCT04754789
Intensive Statin Treatment in Chinese Coronary Artery Disease Patients Undergoing PCI
NCT01293097
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
STAREE Statin group
Participants in STAREE trial randomised to statin
Echocardiography
Ultrasound of heart
ECG screening
Single lead ECG screening twice daily for two weeks
ECG Screening
12-lead ECG screening
STAREE Placebo group
Participants in STAREE trial randomised to placebo
Echocardiography
Ultrasound of heart
ECG screening
Single lead ECG screening twice daily for two weeks
ECG Screening
12-lead ECG screening
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Echocardiography
Ultrasound of heart
ECG screening
Single lead ECG screening twice daily for two weeks
ECG Screening
12-lead ECG screening
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willing and able to provide informed consent and accept the STAREE-HEART study requirements, including attendance for an echocardiogram and undertaking home monitoring via ECG.
Exclusion Criteria
* Participants who do not wish to be informed of an abnormality under any circumstances, regardless of severity, will not be enrolled in the study.
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Health and Medical Research Council, Australia
OTHER
Curtin University
OTHER
Monash University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ingrid Hopper
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ingrid Hopper
Role: PRINCIPAL_INVESTIGATOR
Monash University
Sophia Zoungas, MBBS PhD FRACP
Role: STUDY_CHAIR
Monash University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Monash University; School of Public Health and Preventative Medicine: STAREE trial
Melbourne, Victoria, Australia
Curtin University
Perth, Western Australia, Australia
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hopper I, Marwick TH, Wolfe R, Amerena J, Curtis AJ, Freedman B, Green DJ, Kaye D, Kolomoisky A, McNeil JJ, Nelson MR, Reid CM, Spark S, Tonkin AM, Wang BH, Zhou Z, Zoungas S. STAREE-HEART: A randomized placebo-controlled trial of atorvastatin effects on a marker of cardiac aging in older individuals without prior cardiovascular disease events: Protocol and baseline description of participants. Am Heart J. 2025 Dec;290:140-152. doi: 10.1016/j.ahj.2025.06.004. Epub 2025 Jun 12.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
APP1165440
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.